Avon Products (NYSE:AVP) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 62,962,408 shares, a growth of 8.9% from the December 15th total of 57,793,390 shares, American Banking News.com reports. On Friday shares of Avon Products Inc. (NYSE:AVP) closed at $7.47. Company’s sales growth for last 5 years was -1.10% and EPS growth for next 5 years is recorded as 3.80%.
On 14 January Bon-Ton Stores, Inc. (NASDAQ: BONT), parent company of Bon-Ton, Bergner’s, Boston Store, Carson’s, Elder-Beerman, Herberger’s and Younkers department stores, raised $430,000 in donations, in partnership with Mario Lopez, through its Give the Gift of a Great Future Campaign this holiday season Bon-Ton Stores Inc. (NASDAQ:BONT) in last trading activity increased 7.27% to close at $6.20. Company weekly performance is -9.62% while its quarterly performance stands at -30.65%. Bon-Ton Stores Inc. (NASDAQ:BONT) is -48.97% away from its 52 week high.
Eldorado Gold Corporation (NYSE:EGO) insider Peter Dubois Lewis sold 12,390 shares of the company’s stock in a transaction that occurred on Friday, January 16th. The shares were sold at an average price of C$8.90, for a total value of C$110,271.00. On last trading day Eldorado Gold Corporation (NYSE:EGO) increased 3.36% to close at $7.39. Its volatility for the week is 6.38% while volatility for the month is 5.50%. EGO’s sales growth for past 5 years was 31.30% and its EPS growth for past 5 years was -31.80%. Eldorado Gold Corporation (NYSE:EGO) monthly performance is 26.98%.
American Financial Group, Inc. (NYSE: AFG) expects to release its 2014 fourth quarter and full year results after 5:00 pm (ET) on Monday, February 2, 2015. American Financial Group Inc. (NYSE:AFG) has 0.30% insider ownership while its institutional ownership stands at 61.80%. In last trading activity company’s stock closed at $59.33.
Zacks reaffirmed their outperform rating on shares of Rosetta Genomics (NASDAQ:ROSG) in a research note issued to investors on Tuesday. The firm currently has a $10.50 price target on the stock. On last trading day Rosetta Genomics, Ltd. (NASDAQ:ROSG) fell -4.05% to close at $3.08. Its volatility for the week is 9.99% while volatility for the month is 5.86%. ROSG’s EPS growth for past 5 years was 49.80%. Rosetta Genomics, Ltd. (NASDAQ:ROSG) monthly performance is 35.09%.